[Adjuvant therapy of breast cancer].
Semiglazov
V F
VF
Abzumanov
A S
AS
Bozhok
A A
AA
Ivanov
V G
VG
Ivanova
O A
OA
Barash
N Iu
NIu
Topuzov
E E
EE
Seleznev
I K
IK
Migmanova
N Sh
NSh
Popova
R T
RT
Nurgaziev
K Sh
KSh
D000328:Adult; D000367:Age Factors; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use; D017273:Goserelin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008408:Mastectomy; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010052:Ovariectomy; D011182:Postoperative Care; D011300:Preoperative Care; D011379:Prognosis; D012307:Risk Factors; D013629:Tamoxifen / Q000008:administration & dosage / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D017273:Goserelin; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate
Ad"iuvantnaia terapiia raka molochnoĭ zhelezy.